Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 1066 AL 1080

[Clinical stabilisation in neurodegenerative diseases: clinical study in phase II]

de Font-Réaulx Rojas E, Dorazco-Barragan G.

Rev Neurol. 2010 May 1;50(9):520-8.

Juvenile parkinsonism: epidemiology, diagnosis and treatment

Thomsen TR, Rodnitzky RL.

CNS Drugs. 2010 Jun;24(6):467-77. doi: 10.2165/11533130-000000000-00000.

Deep brain stimulation therapy for Parkinson's disease using frameless stereotaxy: comparison with frame-based surgery

Tai CH, Wu RM, Lin CH, Pan MK, Chen YF, Liu HM, Lu HH, Tsai CW, Tseng SH.

Eur J Neurol. 2010 Nov;17(11):1377-85. doi: 10.1111/j.1468-1331.2010.03035.x.

Clinical pharmacology tyramine challenge study to determine the selectivity of the monoamine oxidase type B (MAO-B) inhibitor rasagiline

Goren T, Adar L, Sasson N, Weiss YM.

J Clin Pharmacol. 2010 Dec;50(12):1420-8. doi: 10.1177/0091270010369674. Epub 2010 May 5.

Compulsive behaviors in patients with Parkinson's disease

Kenangil G, Ozekmekçi S, Sohtaoglu M, Erginöz E.

Neurologist. 2010 May;16(3):192-5. doi: 10.1097/NRL.0b013e31819f952b.

[Saccade: a potential diagnostic tool and drug efficacy test criterion for mental disorders]

Li H, Hu XT, Ma YY.

Dongwuxue Yanjiu. 2010 Feb;31(1):43-9. doi: 10.3724/sp.j.1141.2010.01043.

A single-blind, comparative study of zotepine versus haloperidol in combination with a mood stabilizer for patients with moderate-to-severe mania

Chan HY, Jou SH, Juang YY, Chang CJ, Chen JJ, Chen CH, Chiu NY.

Psychiatry Clin Neurosci. 2010 Apr;64(2):162-9. doi: 10.1111/j.1440-1819.2010.02066.x.

Could a dysfunction of ferritin be a determinant factor in the aetiology of some neurodegenerative diseases?

Quintana C, Gutiérrez L.

Biochim Biophys Acta. 2010 Aug;1800(8):770-82. doi: 10.1016/j.bbagen.2010.04.012. Epub 2010 May 3.

[Rapidly progressive parkinsonism that developed one year after ventriculoperitoneal shunting for idiopathic aqueductal stenosis: a case report]

Sakurai T, Kimura A, Yamada M, Hayashi Y, Tanaka Y, Hozumi I, Inuzuka T.

Brain Nerve. 2010 May;62(5):527-31.

Parkin and Parkinson's disease: differentiated by non-dopaminergic dysfunction?

Stoessl AJ.

Exp Neurol. 2010 Sep;225(1):48-50. doi: 10.1016/j.expneurol.2010.04.015. Epub 2010 May 5.

REM sleep behavior disorder

Frenette E.

Med Clin North Am. 2010 May;94(3):593-614. doi: 10.1016/j.mcna.2010.02.010.

Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: a pathogenetically based approach

van Dijk KD, Teunissen CE, Drukarch B, Jimenez CR, Groenewegen HJ, Berendse HW, van de Berg WD.

Neurobiol Dis. 2010 Sep;39(3):229-41. doi: 10.1016/j.nbd.2010.04.020. Epub 2010 May 6.

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Tolosa E, Weintraub D.

Lancet Neurol. 2010 Jun;9(6):573-80. doi: 10.1016/S1474-4422(10)70106-X. Epub 2010 May 7.

Action observation improves freezing of gait in patients with Parkinson's disease

Pelosin E, Avanzino L, Bove M, Stramesi P, Nieuwboer A, Abbruzzese G.

Neurorehabil Neural Repair. 2010 Oct;24(8):746-52. doi: 10.1177/1545968310368685. Epub 2010 May 7.

Role of transcription factors in cell replacement therapies for neurodegenerative conditions

Thomas M.

Regen Med. 2010 May;5(3):441-50. doi: 10.2217/rme.10.17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias